Arkolith/Insider Trading/CHRS/Form 4

Stilwell McDavid

Chief Financial OfficerCoherus BioSciences, Inc. (CHRS) · full profile →Form 4 · filed Jun 10, 2021
Net Buying
Open-Market Buys
$50K
Open-Market Sells
$0
Net Open-Market Flow
$50K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 9, 2021Buy(P)4K$13.42$50K35K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001567619-21-011972) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML